Update on barriers to human papillomavirus vaccination and effective strategies to promote vaccine acceptance

Current Opinion in Pediatrics

Volumn 28, Issue 3, 2016, Pages 407-412

  Bratic, Julia S ^a   Seyferth, Elisabeth R ^a   Bocchini, Joseph A ^b  

^a Northwell Health   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

cervical cancer; human papillomavirus; human papillomavirus vaccine; immunization rates; provider recommendation

Indexed keywords

WART VIRUS VACCINE;

HEALTH CARE BARRIER; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH PROMOTION; HUMAN; PATIENT EDUCATION; PRIORITY JOURNAL; PROGRAM ACCEPTABILITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; UNITED STATES; VACCINATION; ADOLESCENT; ATTITUDE TO HEALTH; CHILD HEALTH CARE; EDUCATION; EPIDEMIOLOGY; IMMUNIZATION; ORGANIZATION AND MANAGEMENT; PARENT; PATIENT ATTITUDE; PREVENTIVE HEALTH SERVICE; PROTOCOL COMPLIANCE; PSYCHOLOGY; PUBLIC HEALTH; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; PAPILLOMAVIRUS VACCINES; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; PUBLIC HEALTH; UNITED STATES; VACCINATION;

EID: 84964345838     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000353     Document Type: Review

References (26)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1. 0, cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon. globocan. iarc. fr 2013.
2. Healthy People 2020. Immunization and Infectious Diseases: Objectives. Healthy People 2020. U.S. Department of Health and Human Services. Available at: http://www.healthypeople.gov/2020/topics-objectives/topic/immunization-And-infectious-diseases/objectives. [Accessed 16 January 2016].
3. Reagan-Steiner S, Yankey D, Jeyarajah J. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years: United States, 2014. MMWR Morb Mortal Wkly Rep. 2015; 64: 784-792.
4. Ng J, Ye F, Roth L, et al. Human papillomavirus vaccination coverage among female adolescents in managed care plans: United States, 2013. MMWR Morb Mortal Wkly Rep. 2015; 64: 1185-1189.
5. Holman DM, Benard V, Roland KB, et al. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014; 168: 76-82.
6. Schuchat A. HPV ?coverage. N Engl J Med. 2015; 372: 775-776.
7. Dunne EF, Markowitz LE, Saraiya M, et al. CDC grand rounds: reducing the burden of HPV-Associated cancer and disease. MMWR Morb Mortal Wkly Rep. 2014; 63: 69-72.
8. Stokley S, Jeyarajah J, Yankey D, et al. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014: United States. MMWR Morb Mortal Wkly Rep. 2014; 63: 620-624.
9. Gilkey MB, Malo TL, Shah PD, et al. Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiol Biomarkers Prev. 2015; 24: 1673-1679.
10. Perkins RB, Clark JA, Apte G, et al. Missed opportunities for HPV vaccination in adolescent girls: a qualitative study. Pediatrics. 2014; 134: e666-e674.
11. Gilkey MB, Moss JL, Coyne-Beasley T, et al. Physician communication about adolescent vaccination: how is human papillomavirus vaccine different?. Prev Med. 2015; 77: 181.
12. Donahue KL, Stupiansky NW, Alexander AB, Zimet GD. Acceptability of the human papillomavirus vaccine and reasons for nonvaccination among parents of adolescent sons. Vaccine. 2014; 32: 3883-3885.
13. Rahman M, Laz TH, McGrath CJ, Berenson AB. Provider recommendation mediates the relationship between parental human papillomavirus (HPV) vaccine awareness and HPV vaccine initiation and completion among 13-To 17-year-old US adolescent children. Clin Pediatr (Phila) 2015; 54: 371-375.
14. Rubin R. Why the ?no-brainer HPV vaccine is being ignored. JAMA. 2015; 313: 1502-1504.
15. Jacobson RM, Agunwamba AA, St Sauver JL, Finney Rutten LJ. The most effective and promising population health strategies to advance human papillomavirus vaccination. Expert Rev Vaccines. 2016; 15: 257-269.
16. Sussman AL, Helitzer D, Bennett A, et al. Catching up with the HPV vaccine: challenges and opportunities in primary care. Ann Fam Med. 2015; 13: 354-360.
17. Clark SJ, Cowan AE, Filipp SL, et al. Parent perception of provider interactions influences HPV vaccination status of adolescent females. Clin Pediatr (Phila) 2015; doi: 10.1177/0009922815610629. [Epub ahead of print]
18. Clark SJ, Cowan AE, Filipp SL, et al. Parent HPV vaccine perspectives and the likelihood of HPV vaccination of adolescent males. Hum Vaccin Immunother. 2016; 12: 47-51.
19. Moss JL, Reiter PL, Brewer NT. HPV vaccine for teen boys: dyadic analysis of parents and sons beliefs and willingness. Prev Med. 2015; 78: 65-71.
20. Mortensen GL, Adam M, Idtaleb L. Parental attitudes towards male human papillomavirus vaccination: a pan-European cross-sectional survey. BMC Public Health. 2015; 15: 624.
21. Perez S, Shapiro GK, Brown CA, et al. I didnt even know boys could get the vaccine: parents reasons for human papillomavirus (HPV) vaccination decision making for their sons. Psychooncology 2015 doi 10.1002/pon.3894. [Epub ahead of print]
22. Seven M, GÜvenç G, ahin E, AkyÜz A. Attitudes to HPV vaccination among parents of children aged 10 to 13 years. J Pediatr Adolesc Gynecol. 2015; 28: 382-386.
23. Vadaparampil ST, Malo TL, Kahn JA, et al. Physicians human papillomavirus vaccine recommendations, 2009 and 2011. Am J Prev Med. 2014; 46: 80-84.
24. Rand CM, Brill H, Albertin C, et al. Effectiveness of centralized text message reminders on human papillomavirus immunization coverage for publicly insured adolescents. J Adolesc Health. 2015; 56: S17-S20.
25. Tiro JA, Sanders JM, Pruitt SL, et al. Promoting HPV vaccination in safety-net clinics: a randomized trial. Pediatrics. 2015; 136: 850-859.
26. Moss JL, Feld AL, OMalley B, et al. Opportunities for increasing human papillomavirus vaccine provision in school health centers. J Sch Health. 2014; 84: 370-378.